Chlamydia muridarum evades growth restriction by the IFN-γ-inducible host resistance factor Irgb10

Journal of Immunology

Volumn 180, Issue 9, 2008, Pages 6237-6245

  Coers, Jörn ^a   Bernstein Hanley, Isaac ^a   Grotsky, David ^a   Parvanova, Iana ^b   Howard, Jonathan C ^c   Taylor, Gregory A ^d,e   Dietrich, William F ^f   Starnbach, Michael N ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF COLOGNE   (Germany)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DURHAM VA MEDICAL CENTER   (United States)

^f NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GAMMA INTERFERON; GUANOSINE TRIPHOSPHATASE; IMMUNITY RELATED GUANOSINE TRIPHOSPHATASE; PROTEIN IRGA6; PROTEIN IRGB10; PROTEIN IRGM1; PROTEIN IRGM3; UNCLASSIFIED DRUG; IIGP1 PROTEIN, MOUSE; IRGB10 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; FIBROBLAST; GENE DELETION; HOST RESISTANCE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; CELL CULTURE; CELL INCLUSION; CHLAMYDIASIS; EVOLUTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INNATE IMMUNITY; MICROBIOLOGY; MOUSE MUTANT;

ANIMALS; CELLS, CULTURED; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CHLAMYDIA TRACHOMATIS; EVOLUTION; GTP PHOSPHOHYDROLASES; IMMUNITY, NATURAL; INCLUSION BODIES; INTERFERON TYPE II; MICE; MICE, KNOCKOUT;

EID: 44449088023     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.9.6237     Document Type: Article

References (60)

1. Belland, R., D. M. Ojcius, and G. I. Byrne. 2004. Chlamydia. Nat. Rev. Microbiol. 2: 530-531.
2. Resnikoff, S., D. Pascolini, D. Etya'ale, I. Kocur, R. Pararajasegaram, G. P. Pokharel, and S. P. Mariotti. 2004. Global data on visual impairment in the year 2002. Bull. W. H. O. 82: 844-851.
3. World Health Organization. 2001. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. World Health Organization, Geneva. p. 10.
4. Brunham, R. C., and J. Rey-Ladino. 2005. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat. Rev. Immunol. 5: 149-161. (Pubitemid 40208904)
5. McClarty, G., H. D. Caldwell, and D. E. Nelson. 2007. Chlamydial interferon γ immune evasion influences infection tropism. Curr. Opin. Microbiol. 10: 47-51. (Pubitemid 46216874)
6. Morrison, R. P., and H. D. Caldwell. 2002. Immunity to murine chlamydial genital infection. Infect. Immun. 70: 2741-2751. (Pubitemid 34564127)
7. Abdelrahman, Y. M., and R. J. Belland. 2005. The chlamydial developmental cycle. FEMS Microbiol. Rev. 29: 949-959. (Pubitemid 41416845)
8. Fields, K. A., and T. Hackstadt. 2002. The chlamydial inclusion: escape from the endocytic pathway. Annu. Rev. Cell. Dev. Biol. 18: 221-245. (Pubitemid 35387351)
9. Read, T. D., R. C. Brunham, C. Shen, S. R. Gill, J. F. Heidelberg, O. White, E. K. Hickey, J. Peterson, T. Utterback, K. Berry, et al. 2000. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res. 28: 1397-1406. (Pubitemid 30142683)
10. Read, T. D., G. S. Myers, R. C. Brunham, W. C. Nelson, I. T. Paulsen, J. Heidelberg, E. Holtzapple, H. Khouri, N. B. Federova, H. A. Carty, et al. 2003. Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae. Nucleic Acids Res. 31: 2134-2147. (Pubitemid 37442081)
11. Stephens, R. S., S. Kalman, C. Lammel, J. Fan, R. Marathe, L. Aravind, W. Mitchell, L. Olinger, R. L. Tatusov, Q. Zhao, et al. 1998. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282: 754-759. (Pubitemid 28489390)
12. Morrison, R. P. 2000. Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of γ interferon. Infect. Immun. 68: 6038-6040.
13. Nelson, D. E., D. P. Virok, H. Wood, C. Roshick, R. M. Johnson, W. M. Whitmire, D. D. Crane, O. Steele-Mortimer, L. Kari, G. McClarty, and H. D. Caldwell. 2005. Chlamydial IFN-γ immune evasion is linked to host infection tropism. Proc. Natl. Acad. Sci. USA 102: 10658-10663. (Pubitemid 41061610)
14. Roshick, C., H. Wood, H. D. Caldwell, and G. McClarty. 2006. Comparison of γ interferon-mediated antichlamydial defense mechanisms in human and mouse cells. Infect. Immun. 74: 225-238. (Pubitemid 43023077)
15. Fehlner-Gardiner, C., C. Roshick, J. H. Carlson, S. Hughes, R. J. Belland, H. D. Caldwell, and G. McClarty. 2002. Molecular basis defining human Chlamydia trachomatis tissue tropism: a possible role for tryptophan synthase. J. Biol. Chem. 277: 26893-26903.
16. Taylor, M. W., and G. S. Feng. 1991. Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5: 2516-2522. (Pubitemid 21905800)
17. Thomas, S. M., L. F. Garrity, C. R. Brandt, C. S. Schobert, G. S. Feng, M. W. Taylor, J. M. Carlin, and G. I. Byrne. 1993. IFN-γ-mediated antimicrobial response: indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth. J. Immunol. 150: 5529-5534. (Pubitemid 23180667)
18. Beatty, W. L., T. A. Belanger, A. A. Desai, R. P. Morrison, and G. I. Byrne. 1994. Tryptophan depletion as a mechanism of γ interferon-mediated chlamydial persistence. Infect. Immun. 62: 3705-3711. (Pubitemid 24264310)
19. Beatty, W. L., R. P. Morrison, and G. I. Byrne. 1994. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol. Rev. 58: 686-699. (Pubitemid 124005209)
20. Caldwell, H. D., H. Wood, D. Crane, R. Bailey, R. B. Jones, D. Mabey, I. Maclean, Z. Mohammed, R. Peeling, C. Roshick, et al. 2003. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J. Clin. Invest. 111: 1757-1769. (Pubitemid 38057756)
21. Bernstein-Hanley, I., J. Coers, Z. R. Balsara, G. A. Taylor, M. N. Starnbach, and W. F. Dietrich. 2006. The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice. Proc. Natl. Acad. Sci. USA 103: 14092-14097. (Pubitemid 44452985)
22. Shao, F., P. O. Vacratsis, Z. Bao, K. E. Bowers, C. A. Fierke, and J. E. Dixon. 2003. Biochemical characterization of the Yersinia YopT protease: cleavage site and recognition elements in Rho GTPases. Proc. Natl. Acad. Sci. USA 100: 904-909. (Pubitemid 36183928)
23. Collazo, C. M., G. S. Yap, G. D. Sempowski, K. C. Lusby, L. Tessarollo, G. F. Woude, A. Sher, and G. A. Taylor. 2001. Inactivation of LRG-47 and IRG-47 reveals a family of interferon γ-inducible genes with essential, pathogen-specific roles in resistance to infection. J. Exp. Med. 194: 181-188.
24. Taylor, G. A., C. M. Collazo, G. S. Yap, K. Nguyen, T. A. Gregorio, L. S. Taylor, B. Eagleson, L. Secrest, E. A. Southon, S. W. Reid, et al. 2000. Pathogen-specific loss of host resistance in mice lacking the IFN-γ-inducible gene IGTP. Proc. Natl. Acad. Sci. USA 97: 751-755. (Pubitemid 30070381)
25. Martens, S., I. Parvanova, J. Zerrahn, G. Griffiths, G. Schell, G. Reichmann, and J. C. Howard. 2005. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog. 1: e24.
26. Parvanova, I. 2005. Analysis of the role of the p47 GTPase IIGP1 in resistance against intracellular pathogens. Doctoral dissertation, University of Cologne, Cologne, Germany.
27. Bernstein-Hanley, I., Z. R. Balsara, W. Ulmer, J. Coers, M. N. Starnbach, and W. F. Dietrich. 2006. Genetic analysis of susceptibility to Chlamydia trachomatis in mouse. Genes Immun. 7: 122-129. (Pubitemid 43336054)
28. Howard, L., N. S. Orenstein, and N. W. King. 1974. Purification on renografin density gradients of Chlamydia trachomatis grown in the yolk sac of eggs. Appl. Microbiol. 27: 102-106.
29. Cotter, T. W., Q. Meng, Z. L. Shen, Y. X. Zhang, H. Su, and H. D. Caldwell. 1995. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect. Immun. 63: 4704-4714.
30. Martens, S., K. Sabel, R. Lange, R. Uthaiah, E. Wolf, and J. C. Howard. 2004. Mechanisms regulating the positioning of mouse p47 resistance GTPases LRG-47 and IIGP1 on cellular membranes: retargeting to plasma membrane induced by phagocytosis. J. Immunol. 173: 2594-2606. (Pubitemid 39063119)
31. Butcher, B. A., R. I. Greene, S. C. Henry, K. L. Annecharico, J. B. Weinberg, E. Y. Denkers, A. Sher, and G. A. Taylor. 2005. p47 GTPases regulate Toxoplasma gondii survival in activated macrophages. Infect. Immun. 73: 3278-3286. (Pubitemid 40745867)
32. Taylor, G. A., M. Jeffers, D. A. Largaespada, N. A. Jenkins, N. G. Copeland, and G. F. Woude. 1996. Identification of a novel GTPase, the inducibly expressed GTPase, that accumulates in response to interferon γ. J. Biol. Chem. 271: 20399-20405. (Pubitemid 26281808)
33. Miyairi, I., V. R. Tatireddigari, O. S. Mahdi, L. A. Rose, R. J. Belland, L. Lu, R. W. Williams, and G. I. Byrne. 2007. The p47 GTPases Iigp2 and Irgb10 regulate innate immunity and inflammation to murine Chlamydia psittaci infection. J. Immunol. 179: 1814-1824.
34. Bekpen, C., J. P. Hunn, C. Rohde, I. Parvanova, L. Guethlein, D. M. Dunn, E. Glowalla, M. Leptin, and J. C. Howard. 2005. The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineage. Genome Biol. 6: R92.
35. Feng, C. G., C. M. Collazo-Custodio, M. Eckhaus, S. Hieny, Y. Belkaid, K. Elkins, D. Jankovic, G. A. Taylor, and A. Sher. 2004. Mice deficient in LRG-47 display increased susceptibility to mycobacterial infection associated with the induction of lymphopenia. J. Immunol. 172: 1163-1168. (Pubitemid 38113777)
36. MacMicking, J. D. 2004. IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol. 25: 601-609. (Pubitemid 39369737)
37. MacMicking, J. D., G. A. Taylor, and J. D. McKinney. 2003. Immune control of tuberculosis by IFN-γ-inducible LRG-47. Science 302: 654-659. (Pubitemid 37310923)
38. Martens, S., and J. Howard. 2006. The interferon-inducible GTPases. Annu. Rev. Cell. Dev. Biol. 22: 559-589.
39. Santiago, H. C., C. G. Feng, A. Bafica, E. Roffe, R. M. Arantes, A. Cheever, G. Taylor, L. Q. Vieira, J. Aliberti, R. T. Gazzinelli, and A. Sher. 2005. Mice deficient in LRG-47 display enhanced susceptibility to Trypanosoma cruzi infection associated with defective hemopoiesis and intracellular control of parasite growth. J. Immunol. 175: 8165-8172. (Pubitemid 41798380)
40. Taylor, G. A., C. G. Feng, and A. Sher. 2004. p47 GTPases: regulators of immunity to intracellular pathogens. Nat. Rev. Immunol. 4: 100-109. (Pubitemid 38209204)
41. Ling, Y. M., M. H. Shaw, C. Ayala, I. Coppens, G. A. Taylor, D. J. Ferguson, and G. S. Yap. 2006. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. J. Exp. Med. 203: 2063-2071. (Pubitemid 44352228)
42. Taylor, G. A., R. Stauber, S. Rulong, E. Hudson, V. Pei, G. N. Pavlakis, J. H. Resau, and G. F. Vande Woude. 1997. The inducibly expressed GTPase localizes to the endoplasmic reticulum, independently of GTP binding. J. Biol. Chem. 272: 10639-10645. (Pubitemid 27181073)
43. Zerrahn, J., U. E. Schaible, V. Brinkmann, U. Guhlich, and S. H. Kaufmann. 2002. The IFN-inducible Golgi- and endoplasmic reticulum- associated 47-kDa GTPase IIGP is transiently expressed during listeriosis. J. Immunol. 168: 3428-3436. (Pubitemid 34250407)
44. Gutierrez, M. G., S. S. Master, S. B. Singh, G. A. Taylor, M. I. Colombo, and V. Deretic. 2004. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119: 753-766. (Pubitemid 40017683)
45. Nelson, D. E., L. D. Taylor, J. G. Shannon, W. M. Whitmire, D. D. Crane, G. McClarty, H. Su, L. Kari, and H. D. Caldwell. 2007. Phenotypic rescue of Chlamydia trachomatis growth in IFN-γ treated mouse cells by irradiated Chlamydia muridarum. Cell. Microbiol. 9: 2289-2298. (Pubitemid 47250299)
46. Finlay, B. B., and G. McFadden. 2006. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124: 767-782. (Pubitemid 43261451)
47. Sansonetti, P. J., and J. P. Di Santo. 2007. Debugging how bacteria manipulate the immune response. Immunity 26: 149-161. (Pubitemid 46329442)
48. Chakravortty, D., I. Hansen-Wester, and M. Hensel. 2002. Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J. Exp. Med. 195: 1155-1166. (Pubitemid 34517141)
49. Haley, B., and P. D. Zamore. 2004. Kinetic analysis of the RNAi enzyme complex. Nat. Struct. Mol. Biol. 11: 599-606. (Pubitemid 38823525)
50. Jackson, A. L., S. R. Bartz, J. Schelter, S. V. Kobayashi, J. Burchard, M. Mao, B. Li, G. Cavet, and P. S. Linsley. 2003. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21: 635-637. (Pubitemid 36638089)
51. Uthaiah, R. C., G. J. Praefcke, J. C. Howard, and C. Herrmann. 2003. IIGP1, an interferon-γ-inducible 47-kDa GTPase of the mouse, showing cooperative enzymatic activity and GTP-dependent multimerization. J. Biol. Chem. 278: 29336-29343. (Pubitemid 36935850)
52. Rzomp, K. A., L. D. Scholtes, B. J. Briggs, G. R. Whittaker, and M. A. Scidmore. 2003. Rab GTPases are recruited to chlamydial inclusions in both a species-dependent and species-independent manner. Infect. Immun. 71: 5855-5870. (Pubitemid 37205639)
53. Resh, M. D. 1999. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta 1451: 1-16. (Pubitemid 29364242)
54. Amor, J. C., D. H. Harrison, R. A. Kahn, and D. Ringe. 1994. Structure of the human ADP-ribosylation factor 1 complexed with GDP. Nature 372: 704-708.
55. Goldberg, J. 1999. Structural and functional analysis of the ARF1-ARFGAP complex reveals a role for coatomer in GTP hydrolysis. Cell 96: 893-902. (Pubitemid 29165091)
56. ras protein farnesyltransferase. Proc. Natl. Acad. Sci. USA 88: 732-736.
57. Singh, S. B., A. S. Davis, G. A. Taylor, and V. Deretic. 2006. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313: 1438-1441. (Pubitemid 44360272)
58. Bafica, A., C. G. Feng, H. C. Santiago, J. Aliberti, A. Cheever, K. E. Thomas, G. A. Taylor, S. N. Vogel, and A. Sher. 2007. The IFN-inducible GTPase LRG47 (Irgm1) negatively regulates TLR4-triggered proinflammatory cytokine production and prevents endotoxemia. J. Immunol. 179: 5514-5522.
59. Parkes, M., J. C. Barrett, N. J. Prescott, M. Tremelling, C. A. Anderson, S. A. Fisher, R. G. Roberts, E. R. Nimmo, F. R. Cummings, D. Soars, et al. 2007. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet. 39: 830-832. (Pubitemid 47014496)
60. Mestas, J., and C. C. Hughes. 2004. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172: 2731-2738. (Pubitemid 38263654)